Assistance With Active Substance Applications
All biocidal products require an authorisation before they can be placed on the market, and the active substances contained in that biocidal product must be previously approved.
The approval of active substances takes place at Union level and the subsequent authorisation of the biocidal products at Member State level. This authorisation can be extended to other Member States by mutual recognition.
The Biocidal Product Regulation (BPR, Regulation (EU) 528/2012) aims to harmonise the market at Union level; simplify the approval of active substances and authorisation of biocidal products. It also promotes the reduction of animal testing by introducing mandatory data sharing obligations and encouraging the use of alternative testing methods.